AbbVie (ABBV) Stock: Why Shares Are Falling Despite Earnings Beat and Strong 2026 Guidance
TLDR AbbVie reported Q4 adjusted earnings of $2.71 per share, beating analyst expectations of $2.65 Revenue reached $16.6 billion in the quarter, surpassing the
2026/02/04